Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2015-08-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2015-2673PMID 26308294PMCID PMC4702452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess

  2014cited by this paper
• Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

  2014cited by this paper
• Steroid diabetes: from mechanism to treatment?

  2014cited by this paper
• Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique

  2014cited by this paper
• Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?

  2014cited by this paper
• Effects of Low-Dose Prednisolone on Hepatic and Peripheral Insulin Sensitivity, Insulin Secretion, and Abdominal Adiposity in Patients With Inflammatory Rheumatologic Disease

  2013cited by this paper
• 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.

  2013cited by this paper
• Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.

  2013cited by this paper
• Liver Upregulation of Genes Involved in Cortisol Production and Action Is Associated with Metabolic Syndrome in Morbidly Obese Patients

  2012cited by this paper
• Increased Whole-Body and Sustained Liver Cortisol Regeneration by 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Men With Type 2 Diabetes Provides a Target for Enzyme Inhibition

  2011cited by this paper
• Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

  2011cited by this paper
• Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial

  2011cited by this paper
• Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients

  2010cited by this paper
• Basu R, Basu A, Grudzien M, Jung P, Jacobson P, Johnson M, Singh R, Sarr M, Rizza RA. Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes 2009;58:39-45

  2009cited by this paper
• Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans

  2009cited by this paper
• Glucocorticoid effect on insulin sensitivity: A time frame

  2008cited by this paper
• Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.

  2007cited by this paper
• Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans.

  2006cited by this paper
• Glucocorticoid-Induced Diabetes Mellitus: Prevalence and Risk Factors in Primary Renal Diseases

  2006cited by this paper
• Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans.

  2005cited by this paper
• Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis.

  2005cited by this paper
• The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans.

  2005cited by this paper
• Why is the management of glucocorticoid deficiency still controversial: a review of the literature

  2005cited by this paper
• The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements.

  2005cited by this paper
• Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

  2004cited by this paper
• Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway.

  2004cited by this paper
• Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

  2003cited by this paper
• Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers.

  2002cited by this paper
• Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone.

  2002cited by this paper
• Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly

  2002cited by this paper
• A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

  2001cited by this paper
• Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.

  2000cited by this paper
• Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.

  2000cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.

  1997cited by this paper
• 11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism.

  1996cited by this paper
• Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women.

  1996cited by this paper
• 11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism.

  1996cited by this paper
• 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations.

  1995cited by this paper
• The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders.

  1992cited by this paper
• Cortisol production rates measured by liquid chromatography/mass spectrometry.

  1990cited by this paper
• Hormonal regulation of hepatic gluconeogenesis.

  1984cited by this paper
• Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

  1982cited by this paper

• Upregulation of hepatic flavin-containing monooxygenase 3 by increased corticosterone via glucocorticoid receptor contributes to gestational diabetes mellitus.

  2025cites this paper
• Sex-specific metabolic and inflammatory alterations in adult animals vulnerable to prenatal stress exposure.

  2025cites this paper
• A Rare Case of Apparent Mineralocorticoid Excess Presenting as Endocrine Hypertension

  2024cites this paper
• Assessment of steroid enzymes action in children and adolescents with obesity.

  2023cites this paper
• Glucose and lipid metabolism abnormalities in Cushing's syndrome

  2022cites this paper
• Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study

  2022cites this paper
• Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update

  2021cites this paper
• Dexamethasone induces pancreatic β-cell apoptosis through upregulation of TRAIL death receptor.

  2021cites this paper
• The Role of Very Low Calorie Ketogenic Diet in Sympathetic Activation through Cortisol Secretion in Male Obese Population

  2021cites this paper
• Long-term adjustment of hepatic lipid metabolism after chronic stress and the role of FGF21.

  2021cites this paper
• Glucose metabolism in Cushing's syndrome.

  2020influential citation
• Dose threshold for radiation induced fetal programming in a mouse model at 4 months of age: Hepatic expression of genes and proteins involved in glucose metabolism and glucose uptake in brown adipose tissue

  2020cites this paper
• Gum Arabic Modifies Glucocorticoid Metabolic Enzymes Gene Associated with Decreased Plasma Corticosterone Levels in Mice

  2020cites this paper
• Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo

  2020cites this paper
• GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION

  2019cites this paper
• Local Cortisol Elevation Contributes to Endometrial Insulin Resistance in Polycystic Ovary Syndrome

  2018cites this paper
• Alterations of Cortisol Metabolism in Human Disorders

  2018cites this paper
• Fetal programming from sub-lethal radiation: glucose metabolism in the liver and brown adipose tissue

  2018cites this paper
• Stress and Obesity: Are There More Susceptible Individuals?

  2018cites this paper
• Glucose metabolism in Cushing ’ s syndrome Glucose metabolism abnormalities in Cushing ’ s syndrome : from molecular basis to clinical management

  2017cites this paper
• Das Karzinom in der Polarität zwischen Stoffwechsel- und Nerven-Sinnes-System – Konsequenzen für die Therapie

  2017cites this paper
• Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options

  2017cites this paper
• Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management

  2017cites this paper
• Glukokortikoidinduceret diabetes og risikofaktorer under højdosisbehandling

  year unknowncites this paper